Neurocrine Biosciences

Neurocrine Stock Jumps 10% After Hours: Revenue Up 41% as Ingrezza Guidance Rises

2026-11-02

Neurocrine Biosciences (NASDAQ: NBIX) jumped about 10% in after-hours trading on Monday, November 2, 2026, after the San Diego biotech reported third-quarter revenue up 41% year over year to $1.1 b...